These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 25519964)

  • 1. [Infrastructure for the clinical research of muscular dystrophies: remudy and MDCTN].
    Kimura E; Nakamura H; Mitsuhashi S; Takeuchi F; Mori-Yoshimura M; Shimizu R; Komaki H; Hayashi YK; Nishino I; Kawai M; Takeda S
    Rinsho Shinkeigaku; 2014; 54(12):1069-70. PubMed ID: 25519964
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Remudy].
    Kimura E; Nakamura H; Nishino I
    Brain Nerve; 2014 Nov; 66(11):1396-402. PubMed ID: 25407075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical trial network for the promotion of clinical research for rare diseases in Japan: muscular dystrophy clinical trial network.
    Shimizu R; Ogata K; Tamaura A; Kimura E; Ohata M; Takeshita E; Nakamura H; Takeda S; Komaki H
    BMC Health Serv Res; 2016 Jul; 16():241. PubMed ID: 27401940
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Registry of muscular dystrophy (Remudy). Construction of the patient self-report registry and collaboration with overseas network].
    Nakamura H; Kawai M
    Rinsho Shinkeigaku; 2011 Nov; 51(11):901-2. PubMed ID: 22277410
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Infrastructure for new drug development to treat muscular dystrophy: current status of patient registration (remudy)].
    Nakamura H; Kimura E; Kawai M
    Brain Nerve; 2011 Nov; 63(11):1279-84. PubMed ID: 22068481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nationwide patient registry for GNE myopathy in Japan.
    Mori-Yoshimura M; Hayashi YK; Yonemoto N; Nakamura H; Murata M; Takeda S; Nishino I; Kimura E
    Orphanet J Rare Dis; 2014 Oct; 9():150. PubMed ID: 25303967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Establishment of an evaluation method for muscular dystrophy and a patient registration system for clinical trials].
    Kawai M
    Rinsho Shinkeigaku; 2009 Nov; 49(11):863-6. PubMed ID: 20030232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Background, introduction and activity of the Japan Primary Registries Network.
    Shiokawa T
    J Evid Based Med; 2009 Feb; 2(1):41-3. PubMed ID: 21348982
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The NCI All Ireland Cancer Conference.
    Johnston PG; Daly PA; Liu E
    Oncologist; 1999; 4(4):275-277. PubMed ID: 10545862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comprehensive database of Duchenne and Becker muscular dystrophy patients (0-18 years old) in East China.
    Li X; Zhao L; Zhou S; Hu C; Shi Y; Shi W; Li H; Liu F; Wu B; Wang Y
    Orphanet J Rare Dis; 2015 Jan; 10():5. PubMed ID: 25612904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A checklist for clinical trials in rare disease: obstacles and anticipatory actions-lessons learned from the FOR-DMD trial.
    Crow RA; Hart KA; McDermott MP; Tawil R; Martens WB; Herr BE; McColl E; Wilkinson J; Kirschner J; King WM; Eagle M; Brown MW; Hirtz D; Lochmuller H; Straub V; Ciafaloni E; Shieh PB; Spinty S; Childs AM; Manzur AY; Morandi L; Butterfield RJ; Horrocks I; Roper H; Flanigan KM; Kuntz NL; Mah JK; Morrison L; Darras BT; von der Hagen M; Schara U; Wilichowski E; Mongini T; McDonald CM; Vita G; Barohn RJ; Finkel RS; Wicklund M; McMillan HJ; Hughes I; Pegoraro E; Bryan Burnette W; Howard JF; Thangarajh M; Campbell C; Griggs RC; Bushby K; Guglieri M
    Trials; 2018 May; 19(1):291. PubMed ID: 29793540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of biobanks on research outcomes in rare diseases: a systematic review.
    Garcia M; Downs J; Russell A; Wang W
    Orphanet J Rare Dis; 2018 Nov; 13(1):202. PubMed ID: 30419920
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patient Registries and Trial Readiness in Myotonic Dystrophy--TREAT-NMD/Marigold International Workshop Report.
    Thompson R; Schoser B; Monckton DG; Blonsky K; Lochmüller H
    Neuromuscul Disord; 2009 Dec; 19(12):860-6. PubMed ID: 19846307
    [No Abstract]   [Full Text] [Related]  

  • 14. Accelerating Rare Disease Drug Development: Lessons Learned from Muscular Dystrophy Patient Advocacy Groups.
    Huml RA; Dawson J; Bailey M; Nakas N; Williams J; Kolochavina M; Huml JR
    Ther Innov Regul Sci; 2021 Mar; 55(2):370-377. PubMed ID: 32974874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comprehensive analysis for genetic diagnosis of Dystrophinopathies in Japan.
    Okubo M; Goto K; Komaki H; Nakamura H; Mori-Yoshimura M; Hayashi YK; Mitsuhashi S; Noguchi S; Kimura E; Nishino I
    Orphanet J Rare Dis; 2017 Aug; 12(1):149. PubMed ID: 28859693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The French National Registry of patients with Facioscapulohumeral muscular dystrophy.
    Guien C; Blandin G; Lahaut P; Sanson B; Nehal K; Rabarimeriarijaona S; Bernard R; Lévy N; Sacconi S; Béroud C
    Orphanet J Rare Dis; 2018 Dec; 13(1):218. PubMed ID: 30514324
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Muscular diseases: epidemiology of progressive muscular dystrophies].
    Schergna E; Armani M
    Minerva Med; 1981 Apr; 72(17):1045-9. PubMed ID: 6939970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medical Attitudes Survey for Female Dystrophinopathy Carriers in Japan.
    Kobayashi M; Hatakeyama T; Ishizaki M; Adachi K; Morita M; Yonemoto N; Matsumura T; Toyoshima I; Kimura E
    Intern Med; 2018 Aug; 57(16):2325-2332. PubMed ID: 29526935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Establishment of a Comprehensive Information Infrastructure and a Support Organization for Rare Disease Research in Japan (RADDAR-J).
    Yamaguchi I; Furusawa Y; Kawaguchi T; Yagishita N; Tanzawa K; Yamano Y; Matsuda F
    Stud Health Technol Inform; 2019 Aug; 264():1080-1083. PubMed ID: 31438091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The TREAT-NMD care and trial site registry: an online registry to facilitate clinical research for neuromuscular diseases.
    Rodger S; Lochmüller H; Tassoni A; Gramsch K; König K; Bushby K; Straub V; Korinthenberg R; Kirschner J
    Orphanet J Rare Dis; 2013 Oct; 8():171. PubMed ID: 24148153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.